ArticleCancer biology & therapy2019

The histone deacetylase inhibitor Suberoylanilide Hydroxamic Acid (SAHA) as a therapeutic agent in rhabdomyosarcoma.

Sandra E Ghayad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.